AVALO THERAPEUTICS INC (AVTX)
US05338F3064 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -31.54M | -41.66M | -84.38M | -63.50M | -16.07M | |||
| Depreciation Amortization | 158.00K | 170.00K | 1.66M | 1.84M | 3.88M | |||
| Income Taxes - Deferred | 14.00K | 30.00K | 20.00K | 200.00K | 20.00K | |||
| Change In Working Capital | -9.24M | 4.77M | 2.84M | -4.44M | -2.03M | |||
| Interest Paid | 1.93M | 2.93M | 1.59M | 0.00 | 1.05M | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 470.00K | 1.80M | |||
| Other non cash items | 9.93M | 9.94M | 8.97M | 25.36M | -4.94M | |||
| OPERATING CASH FLOW | -30.68M | -26.75M | -70.89M | -40.54M | -19.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -158.00K | -100.00K | -110.00K | -60.00K | -260.00K | |||
| Other Investing Activity | 25.00K | N/A | 0.00 | 11.19M | -180.00K | |||
| INVESTING CASH FLOW | -133.00K | -100.00K | -110.00K | 11.13M | -440.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -21.24M | -14.81M | 32.90M | 0.00 | -260.00K | |||
| Stock Issued/Repurchased | 46.29M | 110.00K | 73.86M | 40.99M | 10.02M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 3.79M | 2.79M | |||
| FINANCING CASH FLOW | 25.04M | -14.70M | 106.76M | 44.78M | 12.56M | |||
| CHANGE IN CASH | -5.77M | -41.55M | 35.76M | 15.37M | -7.01M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.68M | -26.75M | -70.89M | -40.54M | -19.13M | |||
| Capital Expenditure | -158.00K | -100.00K | -110.00K | -60.00K | -260.00K | |||
| FREE CASH FLOW | -30.84M | -26.85M | -71.00M | -40.60M | -19.39M | |||
All data in USD